The European Food Supplement Project combined nutrivigilance, reports, poison-centre information and product screening to identify topics requiring further scientific and regulatory attention.

For a scouting team, the report can become an operating checklist. Before assessing commercial attractiveness, the team should document botanical or microbial identity, plant part, process, preparation, dose, specifications, contaminants and history of use.

A second layer concerns the safety signal: literature, adverse cases, interactions, vulnerable populations, cumulative exposure and data quality must be tied to the actual form proposed by the supplier.

Inclusion in the report does not equal prohibition. Its value is anticipatory: it shows where uncertainty can become project risk and where additional documentation should be requested before investing in development and positioning.

Why it matters

A preventive checklist helps R&D, quality, regulatory and procurement review identity, preparation, dose, specifications, contaminants, literature and reports before portfolio entry.

Evidence limit

The report identifies signals for further investigation. It is not a conclusive safety assessment, prohibition or regulatory opinion on an individual product.

Editorial note. This content is intended for industry professionals. It does not constitute medical advice, therapeutic guidance or regulatory advice. Read our editorial method.

Read the original source · EFSA Supporting Publications ↗